|
2,4-Diamino-5-nitropyrimidine
|
|
18620-73-0
|
|
4-[2-[[6-Amino-9-(N-ethyl-b-D-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]benzenepropanoic acid monosodium salt
|
|
120225-64-1
|
|
2-(2-Bromoethyl)pyridine hydrobromide
|
|
72996-65-7
|
|
tert-Butyl N-[1-(aminomethyl)-2-oxabicyclo[2.2.2]octan-4-yl]carbamate
|
|
1417551-73-5
|
|
tert-Butyl 9-bromononanoate
|
|
135982-11-5
|
|
Methyl 4H,5H,6H,7H-thieno[3,2-b]pyridine-6-carboxylate
|
|
2092493-99-5
|
|
CKMB Type II protein
|
|
|
|
1-Methyl-4-(thiophen-2-yl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid
|
|
1356543-40-2
|
|
2-Amino-5-chlorobenzophenone oxime - Bio-X ?
|
|
18097-52-4
|
|
(+)-Melochinine
|
|
70001-21-7
|
|
methyl 3-(2-indol-3-yl-2-oxoacetylamino)thiophene-2-carboxylate
|
|
1024263-82-8
|
|
Caerulomycin A
|
|
21802-37-9
|
|
5-Methoxyindole-3-carboxaldehyde
|
|
10601-19-1
|
|
ARMC10 antibody
|
|
|
|
{2-[(4-Methylcyclohexyl)oxy]pyridin-4-yl}methanamine
|
|
1016673-84-9
|
|
Pimozide
|
|
2062-78-4
|
|
Fmoc-Gln(Trt)-Rink-Amide MBHA Resin
|
|
|
|
2-(Piperidin-2-yl)acetic acid
|
|
19832-04-3
|
|
SPI1 antibody
|
|
|
|
(Trimethylsilyl)methyl Trifluoromethanesulfonate
|
|
64035-64-9
|
|
Glycyrin
|
|
66056-18-6
|
|
4-Cyanocyclohexane-1-carboxylic acid
|
|
4848-16-2
|
|
(2,4-Dioxo-thiazolidin-3-yl)-acetic acid
|
|
31061-24-2
|
|
2-Amino-2-(3,4-dichlorophenyl)acetonitrile hydrochloride
|
|
40658-57-9
|
|
N,N-Dimethyldodecylamine N-oxide - 30% solution in water
|
|
1643-20-5
|
|
PDCL3 antibody
|
|
|
|
1-[4-(Trifluoromethoxy)phenyl]ethane-1-thiol
|
|
427876-87-7
|
|
Mussaendoside S
|
|
165198-41-4
|
|
4-O-[(2-Azidoethoxyimino)-6-deoxy-β-D-galactopyranosyl]-2-deoxy-α-D-glucopyranose-2,1-oxazoline
|
|
2823367-67-3
|
|
Reactive orange 35
|
|
70210-13-8
|
|
Galectin 3 antibody (PE)
|
|
|
|
(S)-(-)-1-(1-Naphthyl)ethyl amine
|
|
10420-89-0
|
|
Chromium(III) acetate hydroxide, Cr 24%
|
|
39430-51-8
|
|
3-Amino-5-methyloxolan-2-one hydrochloride
|
|
3620-45-9
|
|
5-Azaspiro[2.5]octan-6-one
|
|
1378599-96-2
|
|
Transaldolase antibody (HRP)
|
|
|
|
1-(Cyclobutylmethyl)-1H-pyrazole-4-sulfonamide
|
|
1544805-20-0
|
|
N-(4-bromo-3-methylphenyl)-4-(5-chloro-2-methylphenyl)piperazine-1-carboxamide
|
|
1024419-13-3
|
|
1H-1,2,3-Benzotriazole-5-carbaldehyde
|
|
70938-42-0
|
|
Ethyl 2-(aminomethyl)-1,3-thiazole-4-carboxylate dihydrochloride
|
|
1306603-28-0
|
|
4-Trifluoromethylumbelliferyl b-D-glucopyranoside
|
|
116981-86-3
|
|
6-Bromo-2,7-dimethylimidazo[1,2-a]pyridine
|
|
1216285-07-2
|
|
6-Cyclopropylpyridine-3-carbonitrile
|
|
1032527-28-8
|
|
1-Cyclopropylpiperazin-2-one hydrochloride
|
|
1803584-95-3
|
|
2-[4-(Dimethylcarbamoyl)-1H-1,2,3-triazol-1-yl]acetic acid
|
|
1505149-43-8
|
|
1-(2-Chlorophenyl)-2-(cyanosulfanyl)ethan-1-one
|
|
19339-58-3
|
|
Fmoc-L-Asp-ODmb
|
|
155866-25-4
|
|
mini-ANP
|
|
|
|
7-bromo-2,3-dimethyl-2h-indazole
|
|
845751-62-4
|
|
2-Chloro-N-ethyl-N-[(3-fluorophenyl)methyl]acetamide
|
|
923138-01-6
|
|
ENAC beta antibody
|
|
|
|
Methyl 7-methyl-4-oxo-4-chromene-2-carboxylate
|
|
108123-49-5
|
|
Sofosbuvir impurity J
|
|
1334513-10-8
|
|
tert-Butyl 3-{[(tert-butoxy)carbonyl](hydroxy)amino}azetidine-1-carboxylate
|
|
2375259-29-1
|
|
Methyl2-amino-2-(4-tert-butylphenyl)acetate hydrochloride
|
|
142524-46-7
|
|
N-Cyclobutylazetidin-3-amine, bis(trifluoroacetic acid)
|
|
2126176-83-6
|
|
Peptide YY (Human)-EIA Kit (1ea)
|
|
|
|
EOS 60387
|
|
1001180-45-5
|
|
3-Benzyloxybenzaldehyde
|
|
1700-37-4
|
|
Proflavine hemisulfate
|
|
1811-28-5
|
|
Methyl 5-(hydroxymethyl)-2-furoate
|
|
36802-01-4
|
|
Palmitoyl-DL-carnitine
|
|
1935-18-8
|
|
Methyl 7-hydroxy-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate
|
|
224313-88-6
|
|
(R)-2-Amino-2-methyl-N-[4-phenyl-1-[[4-[2-[2-(1H-tetrazol-5-yl)ethyl]phenyl]-1-piperidinyl]carbonyl]butyl]propanamide
|
|
170842-46-3
|
|
Formononetin-7-acetate
|
|
13293-49-7
|
|
N-(((2-methoxyethyl)amino)thioxomethyl)-2-thienylformamide
|
|
939265-40-4
|
|
Biotinylated TAT (47-57)
|
|
|
|
UCP5 Blocking Peptide (Rat)
|
|
|
|
5-(Chloromethyl)-1-cyclobutyl-1H-1,2,3,4-tetrazole
|
|
1344114-53-9
|
|
5-Acetyl-3,3-dimethyl-2,3-dihydro-1H-indol-2-one
|
|
855420-20-1
|
|
N-[6-(Trifluoromethyl)piperidin-3-yl]acetamide
|
|
1546318-01-7
|
|
Antennapedia peptide Arg
|
|
|
|
3-(2-Methoxyethoxy)propanenitrile
|
|
35633-50-2
|
|
(+) -1- 3- 5- (Aminocarbonyl) - 6- (3, 4- difluorophenyl) - 4- ethyl- 3, 4- dihydro- 2- oxo- 1(2H) - pyrimidinyl carbonyl amin o pro pyl - 4- phenyl- 4- Piperidinecarboxylic acid methyl ester
|
|
179481-04-0
|
|
Elagolix
|
|
834153-87-6
|
|
2-Piperidin-1-yl-propylamine
|
|
54151-70-1
|
|
2-Amino-2-(3,5-dichlorophenyl)propanoic acid
|
|
1270505-34-4
|
|
3-Phenyl-2-(1H-pyrrol-1-yl)propanoic acid
|
|
105264-20-8
|
|
GCFC2 antibody
|
|
|
|
2-Methyl-3-[4-(trifluoromethyl)phenyl]propanoic acid
|
|
1192772-71-6
|
|
KIF9 antibody
|
|
|
|
1-(2,4-Dichlorophenyl)-1,4-diazepane hydrochloride
|
|
1803593-42-1
|
|
3-[(Dimethylamino)methyl]pyrrolidin-3-ol dihydrochloride
|
|
2060034-69-5
|
|
SIDT2 antibody
|
|
|
|
(Asn670, Sta671,Val672)-Amyloid b/A4 Protein Precursor770 (662-675) ammonium
|
|
350228-37-4
|
|
H-Val-Ser-OH
|
|
13588-94-8
|
|
3,4-Dimethoxybenzoic acid anhydride
|
|
24824-54-2
|
|
5H,6H,7H,8H,9H-Pyrido[3,2-b]indol-9-one
|
|
198141-12-7
|
|
UBE2O Blocking Peptide
|
|
|
|
1-(Chloro-Difluoro-Methoxy)-4-Nitro-Benzene
|
|
40750-71-8
|
|
L-tert-Leucine
|
|
20859-02-3
|
|
Pigment orange 17
|
|
15782-04-4
|
|
2-Chlorobenzoic acid
|
|
118-91-2
|
|
1-(2-(2,4-dichlorophenoxy)acetyl)-4-(4-methoxyphenyl)thiosemicarbazide
|
|
69026-42-2
|
|
1,2-Bis(dicyclohexylphosphino)ethane
|
|
23743-26-2
|
|
Methyl phthaloyl chloride
|
|
4397-55-1
|
|
6-Bromo-2-(chloromethyl)-1H-imidazo[4,5-b]pyridine
|
|
857379-84-1
|
|
CDY1 antibody
|
|
|
|
Ethyl 3-amino-4-chloro-1-methyl-1H-pyrrole-2-carboxylate
|
|
100158-71-2
|
|
Adoxosidic acid
|
|
84375-46-2
|